RT Journal Article
SR Electronic
T1 Recent developments in the management of severe asthma
JF Breathe
JO Breathe
FD European Respiratory Society
SP 210178
DO 10.1183/20734735.0178-2021
VO 18
IS 1
A1 Meteran, Howraman
A1 Tønnesen, Louise Lindhardt
A1 Sivapalan, Pradeesh
A1 Ingebrigtsen, Truls Sylvan
A1 Jensen, Jens-Ulrik Stæhr
YR 2022
UL http://breathe.ersjournals.com/content/18/1/210178.abstract
AB Fevipiprant is unlikely to be implemented as a future treatment for severe asthma, while tezepelumab may be a future treatment option for patients with severe asthma with and without eosinophilic inflammation https://bit.ly/3KE1BH4